Flow-Dependent Endothelial Function and Kidney Dysfunction

Seminars in Nephrology

Volumn 32, Issue 2, 2012, Pages 185-191

  Timsit, Marc Olivier ^a   García Cardeña, Guillermo ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Endothelium; Kidney transplantation; KLF2; Renal ischemia; Shear stress

Indexed keywords

ARTICLE; CELL SURFACE; CRYOPRESERVATION; DISEASE ACTIVITY; DISEASE ASSOCIATION; FLOW RATE; GRAFT PERFUSION; GRAFT PRESERVATION; HUMAN; INTERMETHOD COMPARISON; KIDNEY ALLOGRAFT; KIDNEY BLOOD FLOW; KIDNEY BLOOD VESSEL; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MICROVASCULAR ENDOTHELIAL CELL; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; NO REFLOW PHENOMENON; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REGULATORY MECHANISM; SHEAR STRESS; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

ANIMALS; ENDOTHELIUM, VASCULAR; HUMANS; ISCHEMIA; KIDNEY; KIDNEY TRANSPLANTATION; ORGAN PRESERVATION; RENAL CIRCULATION;

EID: 84862098357     PISSN: 02709295     EISSN: 15584488     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2012.02.004     Document Type: Article

References (75)

1. Galbraith C.G., Skalak R., Chien S. Shear stress induces spatial reorganization of the endothelial cell cytoskeleton. Cell Motil Cytoskeleton 1998, 40:317-330.
2. Garcia-Cardeña G., Comander J., Anderson K.R., Blackman B.R., Gimbrone M.A. Biomechanical activation of vascular endothelium as a determinant of its functional phenotype. Proc Natl Acad Sci U S A 2001, 98:4478-4485.
3. Davies P.F. Flow-mediated endothelial mechanotransduction. Physiol Rev 1995, 75:519-560.
4. Davies P.F. Hemodynamic shear stress and the endothelium in cardiovascular pathophysiology. Nat Clin Pract Cardiovasc Med 2009, 6:16-26.
5. Lansman J.B., Hallam T.J., Rink T.J. Single stretch-activated ion channels in vascular endothelial cells as mechanotransducers?. Nature 1987, 325:811-813.
6. Tzima E., Irani-Tehrani M., Kiosses W.B., Dejana E., Schultz D.A., Engelhardt B., et al. A mechanosensory complex that mediates the endothelial cell response to fluid shear stress. Nature 2005, 437:426-431.
7. Khachigian L.M., Resnick N., Gimbrone M.A., Collins T. Nuclear factor-kappa B interacts functionally with the platelet-derived growth factor B-chain shear-stress response element in vascular endothelial cells exposed to fluid shear stress. J Clin Invest 1995, 96:1169-1175.
8. Chu T.J., Peters D.G. Serial analysis of the vascular endothelial transcriptome under static and shear stress conditions. Physiol Genomics 2008, 34:185-192.
9. Yamawaki H., Pan S., Lee R.T., Berk B.C. Fluid shear stress inhibits vascular inflammation by decreasing thioredoxin-interacting protein in endothelial cells. J Clin Invest 2005, 115:733-738.
10. Dayton C., Yamaguchi T., Warren A., Korthuis R.J. Ischemic preconditioning prevents postischemic arteriolar, capillary, and postcapillary venular dysfunction: signaling pathways mediating the adaptive metamorphosis to a protected phenotype in preconditioned endothelium. Microcirculation 2002, 9:73-89.
11. Gimbrone M.A., Topper J.N., Nagel T., Anderson K.R., Garcia-Cardeña G. Endothelial dysfunction, hemodynamic forces, and atherogenesis. Ann N Y Acad Sci 2000, 902:230-239.
12. Chen B.P., Li Y.S., Zhao Y., Chen K.D., Li S., Lao J., et al. DNA microarray analysis of gene expression in endothelial cells in response to 24-h shear stress. Physiol Genomics 2001, 7:55-63.
13. Chiu J.J., Lee P.L., Chang S.F., Chen L.J., Lee C.I., Lin K.M., et al. Shear stress regulates gene expression in vascular endothelial cells in response to tumor necrosis factor-alpha: a study of the transcription profile with complementary DNA microarray. J Biomed Sci 2005, 12:481-502.
14. Dekker R.J., van Soest S., Fontijn R.D., Salamanca S., de Groot P.G., VanBavel E., et al. Prolonged fluid shear stress induces a distinct set of endothelial cell genes, most specifically lung Krüppel-like factor (KLF2). Blood 2002, 100:1689-1698.
15. Grabowski E.F., Reininger A.J., Petteruti P.G., Tsukurov O., Orkin R.W. Shear stress decreases endothelial cell tissue factor activity by augmenting secretion of tissue factor pathway inhibitor. Arterioscler Thromb Vasc Biol 2001, 21:157-162.
16. McCormick S.M., Eskin S.G., McIntire L.V., Teng C.L., Lu C.M., Russell C.G., et al. DNA microarray reveals changes in gene expression of shear stressed human umbilical vein endothelial cells. Proc Natl Acad Sci U S A 2001, 98:8955-8960.
17. Peters D.G., Zhang X.C., Benos P.V., Heidrich-O'Hare E., Ferrell R.E. Genomic analysis of immediate/early response to shear stress in human coronary artery endothelial cells. Physiol Genomics 2002, 12:25-33.
18. Yamawaki H., Lehoux S., Berk B.C. Chronic physiological shear stress inhibits tumor necrosis factor-induced proinflammatory responses in rabbit aorta perfused ex vivo. Circulation 2003, 108:1619-1625.
19. Parmar K.M., Larman H.B., Dai G., Zhang Y., Wang E.T., Moorthy S.N., et al. Integration of flow-dependent endothelial phenotypes by Kruppel-like factor 2. J Clin Invest 2006, 116:49-58.
20. Dekker R.J., Boon R.A., Rondaij M.G., Kragt A., Volger O.L., Elderkamp Y.W., et al. KLF2 provokes a gene expression pattern that establishes functional quiescent differentiation of the endothelium. Blood 2006, 107:4354-4363.
21. Berk B.C. Atheroprotective signaling mechanisms activated by steady laminar flow in endothelial cells. Circulation 2008, 117:1082-1089.
22. Dai G., Kaazempur-Mofrad M.R., Natarajan S., Zhang Y., Vaughn S., Blackman B.R., et al. Distinct endothelial phenotypes evoked by arterial waveforms derived from atherosclerosis-susceptible and -resistant regions of human vasculature. Proc Natl Acad Sci U S A 2004, 101:14871-14876.
23. Anggrahini D.W., Emoto N., Nakayama K., Widyantoro B., Adiarto S., Iwasa N., et al. Vascular endothelial cell-derived endothelin-1 mediates vascular inflammation and neointima formation following blood flow cessation. Cardiovasc Res 2009, 82:143-151.
24. Matharu N.M., McGettrick H.M., Salmon M., Kissane S., Vohra R.K., Rainger G.E., et al. Inflammatory responses of endothelial cells experiencing reduction in flow after conditioning by shear stress. J Cell Physiol 2008, 216:732-741.
25. Milovanova T., Chatterjee S., Hawkins B.J., Hong N., Sorokina E.M., Debolt K., et al. Caveolae are an essential component of the pathway for endothelial cell signaling associated with abrupt reduction of shear stress. Biochim Biophys Acta 2008, 1783:1866-1875.
26. Weight S.C., Bell P.R., Nicholson M.L. Renal ischaemia-reperfusion injury. Br J Surg 1996, 83:162-170.
27. Basile D.P. The endothelial cell in ischemic acute kidney injury: implications for acute and chronic function. Kidney Int 2007, 72:151-156.
28. Sutton T.A., Fisher C.J., Molitoris B.A. Microvascular endothelial injury and dysfunction during ischemic acute renal failure. Kidney Int 2002, 62:1539-1549.
29. Yamamoto T., Tada T., Brodsky S.V., Tanaka H., Noiri E., Kajiya F., et al. Intravital videomicroscopy of peritubular capillaries in renal ischemia. Am J Physiol Renal Physiol 2002, 282:1150-1155.
30. Sutton T.A., Mang H.E., Campos S.B., Sandoval R.M., Yoder M.C., Molitoris B.A. Injury of the renal microvascular endothelium alters barrier function after ischemia. Am J Physiol Renal Physiol 2003, 285:191-198.
31. Norman J.T., Fine L.G. Intrarenal oxygenation in chronic renal failure. Clin Exp Pharmacol Physiol 2006, 33:989-996.
32. Basile D.P., Donohoe D.L., Roethe K., Mattson D.L. Chronic renal hypoxia after acute ischemic injury: effects of L-arginine on hypoxia and secondary damage. Am J Physiol Renal Physiol 2003, 284:338-348.
33. Becherucci F., Mazzinghi B., Ronconi E., Peired A., Lazzeri E., Sagrinati C., et al. The role of endothelial progenitor cells in acute kidney injury. Blood Purif 2009, 27:261-270.
34. Brodsky S.V., Yamamoto T., Tada T., Kim B., Chen J., Kajiya F., et al. Endothelial dysfunction in ischemic acute renal failure: rescue by transplanted endothelial cells. Am J Physiol Renal Physiol 2002, 282:1140-1149.
35. Majno G., Ames A., Chaing J., Wright R.L. No reflow after cerebral ischemia. Lancet 1967, 2:569-570.
36. Kloner R.A., Ganote C.E., Jennings R.B. The "no reflow" phenomenon after temporary occlusion in the dog. J Clin Invest 1974, 54:1496-1508.
37. Summers W.K., Jamison R.L. The no reflow phenomenon in renal ischemia. Lab Invest 1971, 25:635-643.
38. Flores J., DiBona D.R., Beck C.H., Leaf A. The role of cell swelling in ischemic renal damage and the protective effect of hypertonic solute. J Clin Invest 1972, 51:118-126.
39. Eeckhout E., Kern M.J. The coronary no-reflow phenomenon: a review of mechanisms and therapies. Eur Heart J 2001, 22:729-739.
40. Schofer J., Montz R., Mathey D. Scintigraphic evidence of the "no-reflow" phenomenon in human beings after coronary thrombolysis. J Am Coll Cardiol 1985, 5:593-598.
41. Bates E.R., Krell M.J., Dean E.N., N'Neill W.W., Vogel R.A. Demonstration of "no reflow" phenomenon by digital coronary arteriography. Am J Cardiol 1986, 57:177-178.
42. Wilson R.F., Laxson D.D., Lesser J.R., White C.W. Intense microvascular constriction after angioplasty of acute thrombotic coronary arterial lesions. Lancet 1989, 1:807-811.
43. Ito H., Tomooka T., Sakai N., Yu H., Higashino Y., Fujii K., et al. Lack of myocardial perfusion immediately after successful thrombolysis: a predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation 1992, 85:1699-1705.
44. Ito H. No-reflow phenomenon in patients with acute myocardial infarction: its pathophysiology and clinical implications. Acta Med Okayama 2009, 63:161-168.
45. Fuster V., Moreno P.R., Fayad Z.A., Corti R., Badimon J.J. Atherothrombosis and high-risk plaque: part I: evolving concepts. J Am Coll Cardiol 2005, 46:937-954.
46. Patel B., Fisher M. Therapeutic advances in myocardial microvascular resistance: unraveling the enigma. Pharmacol Ther 2010, 127:131-147.
47. Tomai F., Ribichini F., Ghini A.S., Ferrero V., Andò G., Vassanelli C., et al. Elevated C-reactive protein levels and coronary microvascular dysfunction in patients with coronary artery disease. Eur Heart J 2005, 26:2099-2105.
48. Hansen P.R. Inflammatory alterations in the myocardial microcirculation. J Mol Cell Cardiol 1998, 30:2555-2559.
49. Jerome S.N., Doré M., Paulson J.C., Smith C.W., Korthuis R.J. P-selectin and ICAM-1-dependant adherence reactions: role in the genesis of postischemic no-reflow. Am J Physiol 1994, 266:1316-1321.
50. Bonderman D., Teml A., Jakowitsch J., Adlbrecht C., Gyongyosi M., Sperker W., et al. Coronary no-reflow is caused by shedding of active tissue factor from dissected atherosclerotic plaque. Blood 2002, 99:2794-2800.
51. Eitel I., Nowak M., Stehl C., Adams V., Fuernau G., Hildebrand L., et al. Endothelin-1 release in acute myocardial infarction as a predictor of long-term prognosis and no-reflow assessed by contrast-enhanced magnetic resonance imaging. Am Heart J 2010, 159:882-890.
52. Niccoli G., Burzotta F., Galiuto L., Crea F. Myocardial no-reflow in humans. J Am Coll Cardiol 2009, 54:281-292.
53. Schmitz V., Schaser K.D., Olschewski P., Neuhaus P., Puhl G. In vivo visualization of early microcirculatory changes following ischemia/reperfusion injury in human kidney transplantation. Eur Surg Res 2008, 40:19-25.
54. Angelescu M., Kraus T., Wiesel M., Hergesell O., Haberkorn U., Klar E. Assessment of renal graft function by perioperative monitoring of cortical microcirculation in kidney transplantation. Transplantation 2003, 75:1190-1196.
55. Pomfret E.A., Sung R.S., Allan J., Kinkhabwala M., Melancon J.K., Roberts J.P. Solving the organ shortage crisis: the 7th annual American Society of Transplant Surgeons' State-of-the-Art Winter Symposium. Am J Transplant 2008, 8:745-752.
56. Alexander J.W., Zola J.C. Expanding the donor pool: use of marginal donors for solid organ transplantation. Clin Transplant 1996, 10:1-19.
57. Hoogland E.R., Snoeijs M.G., van Heurn L.W. DCD kidney transplantation: results and measures to improve outcome. Curr Opin Organ Transplant 2010, 15:177-182.
58. Pascual J., Zamora J., Pirsch J.D. A systematic review of kidney transplantation from expanded criteria donors. Am J Kidney Dis 2008, 52:553-586.
59. Schold J.D., Sehgal A.R., Srinivas T.R., Poggio E.D., Navaneethan S.D., Kaplan B. Marked variation of the association of ESRD duration before and after wait listing on kidney transplant outcomes. Am J Transplant 2010, 10:2008-2016.
60. Yuan X., Theruvath A.J., Ge X., Floerchinger B., Jurisch A., Garcia-Cardeña G., et al. Machine perfusion or cold storage in organ transplantation: indication, mechanisms, and future perspectives. Transpl Int 2010, 23:561-570.
61. Massie A.B., Desai N.M., Montgomery R.A., Singer A.L., Segev D.L. Improving distribution efficiency of hard-to-place deceased donor kidneys: predicting probability of discard or delay. Am J Transplant 2010, 10:1613-1620.
62. Maathuis M.H., Leuvenink H.G., Ploeg R.J. Perspectives in organ preservation. Transplantation 2007, 83:1289-1298.
63. Opelz G., Döhler B. Multicenter analysis of kidney preservation. Transplantation 2007, 83:247-253.
64. Moers C., Smits J.M., Maathuis M.H., Treckmann J., van Gelder F., Napieralski B., et al. Machine perfusion or cold storage in deceased-donor kidney transplantation. N Engl J Med 2009, 360:7-19.
65. Belzer F.O., Park H.Y., Vetto R.M. Factors influencing renal blood flow during isolated perfusion. Surg Forum 1964, 15:222-224.
66. Hoffmann R.M., Southard J.H., Lutz M., Mackety A., Belzer F.O. Synthetic perfusate for kidney preservation. Its use in 72-hour preservation of dog kidneys. Arch Surg 1983, 118:919-921.
67. Ploeg R.J., Goossens D., Vreugdenhil P., McAnulty J.F., Southard J.H., Belzer F.O. Successful 72-hour cold storage kidney preservation with UW solution. Transplant Proc 1988, 20:935-938.
68. Lee C.Y., Mangino M.J. Preservation methods for kidney and liver. Organogenesis 2009, 5:105-112.
69. Hosgood S.A., Yang B., Bagul A., Mohamed I.H., Nicholson M.L. A comparison of hypothermic machine perfusion versus static cold storage in an experimental model of renal ischemia reperfusion injury. Transplantation 2010, 89:830-837.
70. Tullius S., Garcia-Cardeña G. Organ procurement and perfusion before transplantation. N Eng J Med 2009, 360:78-80.
71. Gracia-Sancho J., Villarreal G., Zhang Y., Yu J.X., Liu Y., Tullius S.G., et al. Flow cessation triggers endothelial dysfunction during organ cold storage conditions: strategies for pharmacologic intervention. Transplantation 2010, 90:142-149.
72. Snoeijs M.G., van Heurn L.W., Buurman W.A. Biological modulation of renal ischemia-reperfusion injury. Curr Opin Organ Transplant 2010, 15:190-199.
73. Matzinger P. The danger model: a renewed sense of self. Science 2002, 296:301-305.
74. Paterson H.M., Murphy T.J., Purcell E.J., Shelley O., Kriynovich S.J., Lien E., et al. Injury primes the innate immune system for enhanced Toll-like receptor reactivity. J Immunol 2003, 171:1473-1483.
75. Zhao J.L., Yang Y.J., Pei W.D., Sun Y.H., Chen J.L. The effect of statins on the no-reflow phenomenon: an observational study in patients with hyperglycemia before primary angioplasty. Am J Cardiovasc Drugs 2009, 9:81-89.